Regulatory Deep Dive

Jun 1, 2022 | Research Report

 

Stay Ahead of MedTech Investing with Zoic Research Reports:

Fill out the form to download this report.

  • The FDA has two approval pathways for medical devices and drugs, depending on the product.
  • A combination product is a mix of two or more regulated components that are combined or mixed together as a single entity.
  • The primary mode of action (PMOA) determines which pathway a combination product will be reviewed under.
  • Regranex is an example of a drug that was approved with a Biologics License Application (BLA).
  • Gene therapy is another example of something that falls under the BLA category because it alters genetic composition and needs to be “metabolized” to produce its effect.

To download this report, please complete the form below

Join Zoic’s Newsletter

Our team of industry experts and professionals provide industry news, guidance and perspective within the life sciences and medtech investment sectors. To see the type of deals and company innovation we pay attention to, consider receiving our biweekly deal flow newsletter.